Meningioma: From basic research to clinical translational study, Volume II

Meningioma: From basic research to clinical translational study, Volume II
Author :
Publisher : Frontiers Media SA
Total Pages : 331
Release :
ISBN-10 : 9782832521397
ISBN-13 : 2832521398
Rating : 4/5 (398 Downloads)

Book Synopsis Meningioma: From basic research to clinical translational study, Volume II by : Hailiang Tang

Download or read book Meningioma: From basic research to clinical translational study, Volume II written by Hailiang Tang and published by Frontiers Media SA. This book was released on 2023-04-25 with total page 331 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Meningioma: From basic research to clinical translational study, Volume II Related Books

Meningioma: From basic research to clinical translational study, Volume II
Language: en
Pages: 331
Authors: Hailiang Tang
Categories: Medical
Type: BOOK - Published: 2023-04-25 - Publisher: Frontiers Media SA

GET EBOOK

Meningioma: From Basic Research to Clinical Translational Study
Language: en
Pages: 409
Authors: Hailiang Tang
Categories: Medical
Type: BOOK - Published: 2021-12-29 - Publisher: Frontiers Media SA

GET EBOOK

Brain Tumor Imaging
Language: en
Pages: 166
Authors: Elke Hattingen
Categories: Medical
Type: BOOK - Published: 2015-09-02 - Publisher: Springer

GET EBOOK

This book describes the basics, the challenges and the limitations of state of the art brain tumor imaging and examines in detail its impact on diagnosis and tr
Epidemiology of Brain and Spinal Tumors
Language: en
Pages: 554
Authors: Jahangir Moini
Categories: Medical
Type: BOOK - Published: 2021-04-09 - Publisher: Academic Press

GET EBOOK

Epidemiology of Brain and Spinal Tumors provides a single volume resource on imaging methods and neuroepidemiology of both brain and spinal tumors. The book cov
Glioblastoma: State of the Art and Future Perspectives
Language: en
Pages: 784
Authors: Ghazaleh Tabatabai
Categories:
Type: BOOK - Published: 2020 - Publisher:

GET EBOOK

Glioblastoma is an aggressive incurable primary tumor of the central nervous system. Median overall survival is in the range of 1.5 years even in selected clini